TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
WithdrawnN/A

Reminiscence, Anxiety and Early Alzheimer's Disease

This study seeks to establish the acceptability and evaluate the limited efficacy of Simple Reminiscence (SR), a home-delivered non-pharmacological intervention designed to relieve stress, improve affect, and prevent or quell disruptive or

Atlanta, Georgia, United StatesView details
CompletedPhase 1

Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants

The primary objectives of this study are to evaluate the absolute bioavailability of a single, fixed sub-cutaneous (SC) dose of aducanumab compared with a single, weight-based intra-venous (IV) dose in healthy participants and to characteri

Evansville, Indiana, United States+1 moreView details
Not yet recruiting

Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

According to the World Health Organization, China will become the "oldest" country in the world by 2050, with 35 percent of the elderly population. At present, in the Chinese population of 60 years old, there are about 15.07 million dementi

Multiple locationsView details
CompletedEARLY_Phase 1

Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants

The primary objectives of this study are to characterize \[18F\]molecular neuroimaging (MNI)-1020, a positron emission tomography (PET) radioligand for imaging tau pathology, to visually and quantitatively assess and compare brain uptake an

New Haven, Connecticut, United StatesView details
Not yet recruitingN/A

Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum

The goal of this clinical trial is to explore and verify the preventive effects of melatonin on the progression of Alzheimer's disease. The study aims to analyze the changes in blood biomarkers (phosphorylated tau, glial fibrillary acidic p

Multiple locationsView details
Not yet recruitingPhase 2

Oral Semaglutide in Patients With Alzheimer's Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disease and a major global healthcare burden. Currently, the disease is only treated symptomatically and an effective disease-modifying therapy (DMT) that may slow the disease prog

Multiple locationsView details
Completed

The Swedish BioFINDER Study

The present study aims at combining biochemical methods with various types of imaging techniques to identify the pathophysiology of Alzheimer's disease (AD). The main interest is to find markers associated with the very early steps in the p

Ängelholm, Sweden+1 moreView details
CompletedPhase 2

Telephone Support for Dementia Caregivers

Caring for a patient with dementia is associated with increased feelings of burden and depression. The proposed study will examine the efficacy of Family Intervention: Telephone Tracking - Dementia (FITT-Dementia), a multi-component, family

Providence, Rhode Island, United StatesView details
RecruitingN/A

Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

The purpose of this study is to develop and test CarePair, a mobile application-based needs assessment and service referral platform for family caregivers of persons with dementia designed to alleviate stress and promote psychosocial well b

Los Angeles, California, United StatesView details
CompletedPhase 1

Salsalate in Patients Mild to Moderate Alzheimer's Disease

The purpose of the study is to test the safety and tolerability of twice daily Salsalate in patients with mild to moderate Alzheimer's Disease. Half of the participants will receive Salsalate and half will receive placebo during the 1-year

San Diego, California, United States+1 moreView details
CompletedPhase 2

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

This study will investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients.

Costa Mesa, California, United States+7 moreView details
Active, not recruitingN/A

Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)

The goal of this study is to explore the efficacy and safety of Near-infrared light Photobiomodulation in patients with mild-moderate Alzheimer's disease(AD). This study will employ a randomized, double-blind, sham-controlled approach.

Beijing, ChinaView details
CompletedPhase 1

A Non-drug Methods Study in Participants With Alzheimer's Disease

This study will investigate the volume, function and composition of the brain using magnetic resonance imaging (MRI) and positron emission tomography (PET) scanning technology in participants with memory complaints or early signs of Alzheim

Cahors, France+15 moreView details
CompletedPhase 2

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

This open label extension study is designed to provide continued access to ANAVEX 2-73 for eligible subjects with mild to moderate Alzheimer's Disease who have previously participated in the Anavex sponsored study ANAVEX2-73-002.

Melbourne, Victoria, Australia+4 moreView details
CompletedPhase 1

Alzheimer's Disease Stem Cells Multiple Infusions

The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a diagnosis of mild to moderate Alzheimer's disease.

Miami, Florida, United StatesView details
RecruitingPhase 3

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Birmingham, Alabama, United States+210 moreView details
Recruiting

Greater-Bay-Area Healthy Aging Brain Study (GHABS)

The goal of this observational study is to learn about the pathophysiology characterization and evolutionary patterns of Alzheimer's disease (AD) in South China older adults. The primary purposes are as follows: 1.

Shenzhen, Other, ChinaView details
CompletedPhase 3

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Rosemead, California, United States+5 moreView details
Active, not recruitingN/A

High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

Alzheimer's disease (AD) is characterized by significant memory loss and toxic protein deposits (amyloid and tau) in the brain. The investigators' lab found a non-invasive way to remove these toxic proteins from the brain in AD mouse models

Cambridge, Massachusetts, United StatesView details
UnknownN/A

How Does Pianistic Musical Training Influence the Development of Alzheimer's Disease?

The goal of this clinical trial is to learn about and describe how pianistic training influences the development of Alzheimer's disease. The key question is: Can pianistic practice influence the development of Alzheimer's disease?

León, Castille and León, SpainView details
Load more trials